Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bonanno

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Oncotargets and Therapy|July 7, 2016
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatmentLaura Bonanno, Giulia Zago, Giuseppe Marulli, et al.
Scientific Reports|August 9, 2024
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLCValeria Tosello, Angela Grassi, Dominic Rose, et al.
Cancer Treatment Reviews|March 20, 2023
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspectiveGiulia Pasello, Daniela Scattolin, Laura Bonanno, et al.
The Oncologist|May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With OutcomeAlberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
Oncotarget|November 8, 2013
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapyLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
British Journal of Cancer|September 29, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitorsElisabetta Zulato, Paola Del Bianco, Giorgia Nardo, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2026
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET studyGiulia Pasello, Giulia Pigato, Cristiana Mulargiu, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Oncotargets and Therapy|July 7, 2016
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatmentLaura Bonanno, Giulia Zago, Giuseppe Marulli, et al.
Scientific Reports|August 9, 2024
Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLCValeria Tosello, Angela Grassi, Dominic Rose, et al.
Cancer Treatment Reviews|March 20, 2023
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspectiveGiulia Pasello, Daniela Scattolin, Laura Bonanno, et al.
The Oncologist|May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With OutcomeAlberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
Oncotarget|November 8, 2013
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapyLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
British Journal of Cancer|September 29, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitorsElisabetta Zulato, Paola Del Bianco, Giorgia Nardo, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2026
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET studyGiulia Pasello, Giulia Pigato, Cristiana Mulargiu, et al.
Pageof 13